These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)]. Nakaya H Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455 [TBL] [Abstract][Full Text] [Related]
4. Calcium antagonists, ventricular arrhythmias, and sudden cardiac death: a major challenge for the future. Opie LH J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S81-6. PubMed ID: 1725011 [TBL] [Abstract][Full Text] [Related]
5. Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia. Surawicz B Am Heart J; 1982 Apr; 103(4 Pt 2):698-706. PubMed ID: 6278910 [TBL] [Abstract][Full Text] [Related]
6. The antiarrhythmic and antifibrillatory effects of calcium antagonists. Billman GE J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S107-17. PubMed ID: 1724998 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists. Apostolakos MJ; Varon ME New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275 [TBL] [Abstract][Full Text] [Related]
8. Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Correlation with improvement of ventricular conduction and early arrhythmias in the dog. Clusin WT; Buchbinder M; Ellis AK; Kernoff RS; Giacomini JC; Harrison DC Circ Res; 1984 Jan; 54(1):10-20. PubMed ID: 6692497 [TBL] [Abstract][Full Text] [Related]
9. Control of cardiac arrhythmias by calcium antagonism. Nademanee K; Singh BN Ann N Y Acad Sci; 1988; 522():536-52. PubMed ID: 3288060 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs. Singh BN Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905 [TBL] [Abstract][Full Text] [Related]
11. Role of calcium antagonists in cardiovascular therapy. Dargie H; Rowland E; Krikler D Br Heart J; 1981 Jul; 46(1):8-16. PubMed ID: 7023517 [TBL] [Abstract][Full Text] [Related]
12. Use of calcium antagonists for cardiac arrhythmias. Singh BN; Nademanee K Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological properties and use of calcium channel blockers]. Kostowski W; Obersztyn M Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1701-5. PubMed ID: 6395120 [No Abstract] [Full Text] [Related]
14. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion. Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252 [TBL] [Abstract][Full Text] [Related]
15. [Anti-arrhythmia effects of calcium antagonists]. Gülker H; Ketteler T Z Kardiol; 1989; 78 Suppl 5():49-54. PubMed ID: 2698564 [TBL] [Abstract][Full Text] [Related]
16. The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9. Curtis MJ; Walker MJ Br J Pharmacol; 1988 Aug; 94(4):1275-86. PubMed ID: 3207985 [TBL] [Abstract][Full Text] [Related]
17. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation. Billman GE; Hamlin RL J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218 [TBL] [Abstract][Full Text] [Related]
18. Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamil. Jespersen CM Am J Cardiol; 1996 Jun; 77(16):32D-36D. PubMed ID: 8677896 [TBL] [Abstract][Full Text] [Related]
20. Calcium antagonists. Clinical use in the treatment of arrhythmias. Singh BN; Nademanee K; Baky SH Drugs; 1983 Feb; 25(2):125-53. PubMed ID: 6339197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]